UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology

Journal of lipid research, 2016-11, Vol.57 (11), p.1953-1975

2016

Volltextzugriff (PDF)

High lipoprotein(a) and high risk of mortality

European heart journal, 2019-09, Vol.40 (33), p.2760-2770

2019

Volltextzugriff (PDF)

Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients

Journal of the American College of Cardiology, 2021-03, Vol.77 (11), p.1439-1450

2021

Volltextzugriff (PDF)

Nonfasting Mild-to-Moderate Hypertriglyceridemia and Risk of Acute Pancreatitis

JAMA internal medicine, 2016-12, Vol.176 (12), p.1834

2016

Volltextzugriff (PDF)

Association between low density lipoprotein and all cause and cause specific mortality in Denmark: prospective cohort study

BMJ (Online), 2020-12, Vol.371, p.m4266

2020

Volltextzugriff (PDF)

High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study

The lancet. Diabetes & endocrinology, 2016-07, Vol.4 (7), p.577-587

2016

Volltextzugriff (PDF)

Lipoproteins, Cholesterol, and Atherosclerotic Cardiovascular Disease in East Asians and Europeans

Journal of Atherosclerosis and Thrombosis, 2023/11/01, Vol.30(11), pp.1525-1546

2023

Volltextzugriff (PDF)

Small Dense Low-Density Lipoprotein Cholesterol Predicts Atherosclerotic Cardiovascular Disease in the Copenhagen General Population Study

Journal of the American College of Cardiology, 2020-06, Vol.75 (22), p.2873-2875

2020

Volltextzugriff (PDF)

Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM

Clinical chemistry (Baltimore, Md.), 2018-07, Vol.64 (7), p.1006-1033

2018

Volltextzugriff (PDF)

A third of nonfasting plasma cholesterol is in remnant lipoproteins: Lipoprotein subclass profiling in 9293 individuals

Atherosclerosis, 2019-07, Vol.286, p.97-104

2019

Volltextzugriff (PDF)

Can remnant cholesterol (triglyceride-rich lipoproteins) reclassify estimated risk of atherosclerotic cardiovascular disease?

Current opinion in endocrinology, diabetes, and obesity, 2023-04, Vol.30 (2), p.128-135

2023

Volltextzugriff (PDF)

Low High-Density Lipoprotein Cholesterol to Monitor Long-Term Average Increased Triglycerides

The journal of clinical endocrinology and metabolism, 2020-04, Vol.105 (4), p.e1657-e1666

2020

Volltextzugriff (PDF)

Lipoprotein(a) and Body Mass Compound the Risk of Calcific Aortic Valve Disease

Journal of the American College of Cardiology, 2022-02, Vol.79 (6), p.545-558

2022

Volltextzugriff (PDF)

Smoking as the most important risk factor for chronic pancreatitis in the general population

European journal of epidemiology, 2023, Vol.38 (1), p.95-107

2023

Volltextzugriff (PDF)

Remnant Cholesterol Elicits Arterial Wall Inflammation and a Multilevel Cellular Immune Response in Humans

Arteriosclerosis, thrombosis, and vascular biology, 2017-05, Vol.37 (5), p.969-975

2017

Volltextzugriff (PDF)

The Christmas holidays are immediately followed by a period of hypercholesterolemia

Atherosclerosis, 2019-02, Vol.281, p.121-127

2019

Volltextzugriff (PDF)

How Does Elevated Lipoprotein(a) Cause Aortic Valve Stenosis?

Journal of the American College of Cardiology, 2015-09, Vol.66 (11), p.1247-1249

2015

Volltextzugriff (PDF)

Lipoprotein(a) and cardiovascular disease

The Lancet (British edition), 2024-09, Vol.404 (10459), p.1255-1264

2024

Volltextzugriff (PDF)

Remnant cholesterol, LDL cholesterol, and APOB absolute mass changes explain results of prominent and other fibrate trials

Atherosclerosis, 2024-08, Vol.395

2024

Volltextzugriff (PDF)

Obesity as a Causal Risk Factor for Aortic Valve Stenosis

Journal of the American College of Cardiology, 2020-01, Vol.75 (2), p.163-176

2020

Volltextzugriff (PDF)

A possible explanation for the contrasting results of REDUCE-IT vs. STRENGTH: cohort study mimicking trial designs

European heart journal, 2021-12, Vol.42 (47), p.4807-4817

2021

Volltextzugriff (PDF)

Elevated Remnant Cholesterol Reclassifies Risk of Ischemic Heart Disease and Myocardial Infarction

Journal of the American College of Cardiology, 2022-06, Vol.79 (24), p.2383-2397

2022

Volltextzugriff (PDF)

Elevated Lipoprotein(a) and Risk of Ischemic Stroke

Journal of the American College of Cardiology, 2019-07, Vol.74 (1), p.54-66

2019

Volltextzugriff (PDF)

Triglycerides and remnant cholesterol associated with risk of aortic valve stenosis: Mendelian randomization in the Copenhagen General Population Study

European heart journal, 2020-06, Vol.41 (24), p.2288-2299

2020

Volltextzugriff (PDF)

Worldwide Increasing Use of Nonfasting Rather Than Fasting Lipid Profiles

Clinical chemistry (Baltimore, Md.), 2024-07, Vol.70 (7), p.911-933

2024

Volltextzugriff (PDF)

1 – 25 von 93

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(84)
Mit Volltextzugriff
(76)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology

High lipoprotein(a) and high risk of mortality

Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients

Nonfasting Mild-to-Moderate Hypertriglyceridemia and Risk of Acute Pancreatitis

Association between low density lipoprotein and all cause and cause specific mortality in Denmark: prospective cohort study

High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study

Lipoproteins, Cholesterol, and Atherosclerotic Cardiovascular Disease in East Asians and Europeans

Small Dense Low-Density Lipoprotein Cholesterol Predicts Atherosclerotic Cardiovascular Disease in the Copenhagen General Population Study

Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM

A third of nonfasting plasma cholesterol is in remnant lipoproteins: Lipoprotein subclass profiling in 9293 individuals

Can remnant cholesterol (triglyceride-rich lipoproteins) reclassify estimated risk of atherosclerotic cardiovascular disease?

Low High-Density Lipoprotein Cholesterol to Monitor Long-Term Average Increased Triglycerides

Lipoprotein(a) and Body Mass Compound the Risk of Calcific Aortic Valve Disease

Smoking as the most important risk factor for chronic pancreatitis in the general population

Remnant Cholesterol Elicits Arterial Wall Inflammation and a Multilevel Cellular Immune Response in Humans

The Christmas holidays are immediately followed by a period of hypercholesterolemia

How Does Elevated Lipoprotein(a) Cause Aortic Valve Stenosis?

Lipoprotein(a) and cardiovascular disease

Remnant cholesterol, LDL cholesterol, and APOB absolute mass changes explain results of prominent and other fibrate trials

Obesity as a Causal Risk Factor for Aortic Valve Stenosis

A possible explanation for the contrasting results of REDUCE-IT vs. STRENGTH: cohort study mimicking trial designs

Elevated Remnant Cholesterol Reclassifies Risk of Ischemic Heart Disease and Myocardial Infarction

Elevated Lipoprotein(a) and Risk of Ischemic Stroke

Triglycerides and remnant cholesterol associated with risk of aortic valve stenosis: Mendelian randomization in the Copenhagen General Population Study

Worldwide Increasing Use of Nonfasting Rather Than Fasting Lipid Profiles

Suchergebnisse filtern